SavedAdd your journal

Journals / Türk Radyoloji Seminerleri / 2018 / Cilt: 6 - Sayı: 3

Tiroid Kanserlerinde Tarama, Tanı, İzlem

Artür SALMASLIOĞLU
Mesut BULAKÇI
Pages
483–495
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

SALMASLIOĞLU, A., BULAKÇI, M. (2018). Tiroid Kanserlerinde Tarama, Tanı, İzlem. Türk Radyoloji Seminerleri, Cilt: 6 - Sayı: 3, 483–495. https://ajindex.com/articles/357709

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. . Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15- year study of the incidence of thyroid malignancy. Ann Intern Med 1968
  2. [CrossRef] [2]. Tan, G.H. and H. Gharib, Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997
  3. [CrossRef] [3]. Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009
  4. [CrossRef] [4]. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004
  5. [CrossRef] [5]. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006
  6. [CrossRef] [6]. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014
  7. [CrossRef] [7]. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"-screening and overdiagnosis. N Engl J Med 2014
  8. [CrossRef] [8]. Lin JS, Bowles EJA, Williams SB, Morrison CC. Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2017
  9. [CrossRef] [9]. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, et al. Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2017
  10. [CrossRef] [10]. Galanti MR, Ekbom A, Grimelius L, Yuen J, et al. Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 1997
  11. [CrossRef] [11]. LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid 1994
  12. [CrossRef] [12]. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994
  13. [CrossRef] [13]. McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 2001
  14. [CrossRef] [14]. Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015
  15. [CrossRef] [15]. Walsh S1, Lowery AJ, Evoy D, McDermott EW, Prichard RS. Thyroid lymphoma: recent advan